Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $205.36 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $90.84 | 6 | $0 (2024) |
| Amgen Inc. | $39.07 | 2 | $0 (2019) |
| Circassia Pharmaceuticals Inc | $18.76 | 1 | $0 (2018) |
| PFIZER INC. | $16.22 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $15.04 | 1 | $0 (2018) |
| Astellas Pharma US Inc | $14.00 | 1 | $0 (2018) |
| Lilly USA, LLC | $11.43 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15.46 | 1 | Novo Nordisk Inc ($15.46) |
| 2019 | $19.12 | 1 | Amgen Inc. ($19.12) |
| 2018 | $106.34 | 7 | Novo Nordisk Inc ($27.16) |
| 2017 | $64.44 | 4 | Novo Nordisk Inc ($48.22) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Diabetes | ||||||
| 06/03/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Neuroscience | ||||||
| 09/10/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: UROLOGY | ||||||
| 08/09/2018 | Circassia Pharmaceuticals Inc | TUDORZA PRESSAIR (Drug), NIOX VERO | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: PULMONARYRESPIRATORY DISEASES | ||||||
| 02/26/2018 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/21/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Diabetes | ||||||
| 02/13/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Cardiology | ||||||
| 01/22/2018 | Lilly USA, LLC | FORTEO (Drug) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: Bone Muscle Joint | ||||||
| 01/16/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Diabetes | ||||||
| 09/13/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: Diabetes | ||||||
| 08/21/2017 | PFIZER INC. | PREVNAR - 13 (Biological), TRUMENBA | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: VACCINES | ||||||
| 04/24/2017 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.05 | General |
| 01/30/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 416 | 629 | $77,795 | $24,698 |
| 2022 | 4 | 358 | 600 | $73,179 | $26,065 |
| 2021 | 5 | 414 | 652 | $75,885 | $34,516 |
| 2020 | 5 | 376 | 505 | $51,955 | $19,575 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 156 | 304 | $37,072 | $12,359 | 33.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 121 | 186 | $14,562 | $7,161 | 49.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 109 | 109 | $24,961 | $4,916 | 19.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 30 | 30 | $1,200 | $262.50 | 21.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 163 | 342 | $41,866 | $14,977 | 35.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 109 | 172 | $13,709 | $6,709 | 48.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 75 | 75 | $17,175 | $3,986 | 23.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 11 | $429.00 | $392.86 | 91.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 172 | 339 | $41,152 | $17,764 | 43.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 69 | 69 | $15,801 | $8,833 | 55.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 147 | 218 | $17,361 | $7,491 | 43.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 13 | 13 | $949.00 | $262.24 | 27.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 13 | 13 | $622.00 | $165.42 | 26.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 145 | 219 | $27,918 | $9,841 | 35.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 119 | 168 | $13,925 | $4,922 | 35.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 44 | 47 | $3,880 | $1,879 | 48.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 56 | 59 | $3,578 | $1,588 | 44.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 12 | 12 | $2,654 | $1,344 | 50.6% |
About Dr. Carrie Nicholson, M.D
Dr. Carrie Nicholson, M.D is a Internal Medicine healthcare provider based in Albion, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356366819.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carrie Nicholson, M.D has received a total of $205.36 in payments from pharmaceutical and medical device companies, with $15.46 received in 2024. These payments were reported across 13 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($205.36).
As a Medicare-enrolled provider, Nicholson has provided services to 1,564 Medicare beneficiaries, totaling 2,386 services with total Medicare billing of $104,854. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Albion, MI
- Active Since 07/13/2006
- Last Updated 03/09/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1356366819
Products in Payments
- Victoza (Drug) $55.33
- Repatha (Biological) $19.95
- Aimovig (Biological) $19.12
- TUDORZA PRESSAIR (Drug) $18.76
- PREVNAR - 13 (Biological) $16.22
- Ozempic (Drug) $15.46
- BYDUREON (Drug) $15.04
- MYRBETRIQ (Drug) $14.00
- FORTEO (Drug) $11.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.